Literature DB >> 24059306

Diabetes of the brain: computational approaches and interventional strategies.

Kothandaraman Narasimhan, Meenakumari Govindasamy, Kalamegam Gauthaman, Mohammad A Kamal, Adel M Abuzenadeh, Mohammed Al-Qahtani, Rajaraman Kanagasabai1.   

Abstract

Diabetes mellitus (DM) is characterized by hyperglycemia either due to deficient insulin production (Type 1 Diabetes mellitus) or peripheral insulin resistance of the cells (Type 2 Diabetes mellitus). Both Type 1 Diabetes mellitus and Type 2 Diabetes mellitus are more prevalent and efforts are directed to actively control these metabolic syndromes. Currently, Alzheimer's disease (AD), is gaining popularity as 'Type 3 diabetes' or 'Diabetes of the brain' and it is now evident that this neurodegenerative disease has multiple shared pathology with DM. Alarming is the fact that the incidence of AD might double within the next two decades, and this is certain to cause devastating effects not only to the afflicted individual or the family, but also to the global economy. Methods to either delay the onset or inhibit the progression of AD are therefore necessary. Progressive dementia, increased deposition of amyloid- β protein, neurofibrillary tangles and neuritic plaques in the brain are some of the hallmarks of AD. More understanding of the disease at the cellular and molecular level will enable identifying the possible targets for intervention and pave way for either development of novel or modification of the existing therapeutic options. In this work we have performed semantic data mining analysis on a large collection of most recently published data and identified an updated list of common genes expressed in DM and AD. Functional analysis of these genes revealed both existing and missing links involved in a bigger network associated with both disease conditions. Thus we argue that computational analysis methods help not only in understanding the mechanistic links but also in narrowing down precise targets (genes, proteins, metabolites and signalling pathways) and provide the base for both disease intervention and development of therapeutic options.

Entities:  

Mesh:

Year:  2014        PMID: 24059306     DOI: 10.2174/18715273113126660156

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  6 in total

1.  Alzheimer's Disease and Protein Kinases.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Authors:  Konrad Talbot; Hoau-Yan Wang
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

3.  Lychee seed extract protects against neuronal injury and improves cognitive function in rats with type II diabetes mellitus with cognitive impairment.

Authors:  Yong Tang; Chonglin Yu; Jianming Wu; Haixia Chen; Yuan Zeng; Xiuling Wang; Le Yang; Qibing Mei; Shousong Cao; Dalian Qin
Journal:  Int J Mol Med       Date:  2017-11-09       Impact factor: 4.101

4.  Candidate SNP Markers of Familial and Sporadic Alzheimer's Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Petr Ponomarenko; Irina Chadaeva; Dmitry A Rasskazov; Ekaterina Sharypova; Elena V Kashina; Irina Drachkova; Dmitry Zhechev; Mikhail P Ponomarenko; Ludmila K Savinkova; Nikolay Kolchanov
Journal:  Front Aging Neurosci       Date:  2017-07-20       Impact factor: 5.750

Review 5.  Machine Learning and Data Mining Methods in Diabetes Research.

Authors:  Ioannis Kavakiotis; Olga Tsave; Athanasios Salifoglou; Nicos Maglaveras; Ioannis Vlahavas; Ioanna Chouvarda
Journal:  Comput Struct Biotechnol J       Date:  2017-01-08       Impact factor: 7.271

Review 6.  Pathogenic landscape of idiopathic male infertility: new insight towards its regulatory networks.

Authors:  Narasimhan Kothandaraman; Ashok Agarwal; Muhammad Abu-Elmagd; Mohammed H Al-Qahtani
Journal:  NPJ Genom Med       Date:  2016-08-17       Impact factor: 8.617

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.